|
|
Previous Article | Table of Contents | Next Article 
The CD11b promoter directs high-level expression of reporter genes in
macrophages in transgenic mice [published erratum appears in Blood 1995 Apr
1;85(7):1983]
S Dziennis, RA Van Etten, HL Pahl, DL Morris, TL Rothstein, CM Blosch, RM Perlmutter and DG Tenen
Department of Medicine, Beth Israel Hospital, Boston, MA 02215.
CD11b is the alpha chain of the Mac-1 integrin and is preferentially
expressed in myeloid cells (neutrophils, monocytes, and macrophages). We
have previously shown that the CD11b promoter directs cell-type- specific
expression in myeloid lines using transient transfection assays. To confirm
that these promoter sequences contain the proper regulatory elements for
correct myeloid expression of CD11b in vivo, we have used the -1.7-kb human
CD11b promoter to direct reporter gene expression in transgenic mice.
Stable founder lines were generated with two different reporter genes, a
Thy 1.1 surface marker and the Escherichia coli lacZ (beta-galactosidase)
gene. Analysis of founders generated with each reporter demonstrated that
the CD11b promoter was capable of driving high levels of transgene
expression in murine macrophages for the lifetime of the animals. Similar
to the endogenous gene, transgene expression was preferentially found in
mature monocytes, macrophages, and neutrophils and not in myeloid
precursors. These experiments indicate that the -1.7 CD11b promoter
contains the regulatory elements sufficient for high-level macrophage
expression. This promoter should be useful for targeting heterologous gene
expression to mature myeloid cells.
Volume 85,
Issue 2,
pp. 319-329,
01/15/1995
Copyright © 1995 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. E.A. van der Bogt, A. Y. Sheikh, S. Schrepfer, G. Hoyt, F. Cao, K. J. Ransohoff, R.-J. Swijnenburg, J. Pearl, A. Lee, M. Fischbein, et al.
Comparison of Different Adult Stem Cell Types for Treatment of Myocardial Ischemia
Circulation,
September 30, 2008;
118(14_suppl_1):
S121 - S129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Saxena, J. K. Ondr, A. F. Magnusen, D. H. Munn, and J. D. Katz
The Countervailing Actions of Myeloid and Plasmacytoid Dendritic Cells Control Autoimmune Diabetes in the Nonobese Diabetic Mouse
J. Immunol.,
October 15, 2007;
179(8):
5041 - 5053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hendrickson, D. Senadheera, S. Mishra, K. C. T. Bui, X. Wang, B. Chan, D. Petersen, K. Pepper, and C. Lutzko
Development of Lentiviral Vectors with Regulated Respiratory Epithelial Expression In Vivo
Am. J. Respir. Cell Mol. Biol.,
October 1, 2007;
37(4):
414 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Stoneman, D. Braganza, N. Figg, J. Mercer, R. Lang, M. Goddard, and M. Bennett
Monocyte/Macrophage Suppression in CD11b Diphtheria Toxin Receptor Transgenic Mice Differentially Affects Atherogenesis and Established Plaques
Circ. Res.,
March 30, 2007;
100(6):
884 - 893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bergtold, A. Gavhane, V. D'Agati, M. Madaio, and R. Clynes
FcR-Bearing Myeloid Cells Are Responsible for Triggering Murine Lupus Nephritis
J. Immunol.,
November 15, 2006;
177(10):
7287 - 7295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Okuno, G. Huang, F. Rosenbauer, E. K. Evans, H. S. Radomska, H. Iwasaki, K. Akashi, F. Moreau-Gachelin, Y. Li, P. Zhang, et al.
Potential Autoregulation of Transcription Factor PU.1 by an Upstream Regulatory Element
Mol. Cell. Biol.,
April 1, 2005;
25(7):
2832 - 2845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Cailhier, M. Partolina, S. Vuthoori, S. Wu, K. Ko, S. Watson, J. Savill, J. Hughes, and R. A. Lang
Conditional Macrophage Ablation Demonstrates That Resident Macrophages Initiate Acute Peritoneal Inflammation
J. Immunol.,
February 15, 2005;
174(4):
2336 - 2342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. I. Ghesquiere, M. J. J. Gijbels, M. Anthonsen, P. J. J. van Gorp, I. van der Made, B. Johansen, M. H. Hofker, and M. P. J. de Winther
Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition
J. Lipid Res.,
February 1, 2005;
46(2):
201 - 210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Doyonnas, M. A. LaBarge, A. Sacco, C. Charlton, and H. M. Blau
Hematopoietic contribution to skeletal muscle regeneration by myelomonocytic precursors
PNAS,
September 14, 2004;
101(37):
13507 - 13512.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. DEVCHAND, M. ARITA, S. HONG, G. BANNENBERG, R.-L. MOUSSIGNAC, K. GRONERT, and C. N. SERHAN
Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense
FASEB J,
April 1, 2003;
17(6):
652 - 659.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Okuno, C. S. Huettner, H. S. Radomska, V. Petkova, H. Iwasaki, K. Akashi, and D. G. Tenen
Distal elements are critical for human CD34 expression in vivo
Blood,
December 15, 2002;
100(13):
4420 - 4426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lang, R. L. Rutschman, D. R. Greaves, and P. J. Murray
Autocrine Deactivation of Macrophages in Transgenic Mice Constitutively Overexpressing IL-10 Under Control of the Human CD68 Promoter
J. Immunol.,
April 1, 2002;
168(7):
3402 - 3411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Cho, J. W. Youn, and Y. C. Sung
Cross-Priming as a Predominant Mechanism for Inducing CD8+ T Cell Responses in Gene Gun DNA Immunization
J. Immunol.,
November 15, 2001;
167(10):
5549 - 5557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, Y. Okuno, P. Zhang, H. S. Radomska, H.-m. Chen, H. Iwasaki, K. Akashi, M. J. Klemsz, S. R. McKercher, R. A. Maki, et al.
Regulation of the PU.1 gene by distal elements
Blood,
November 15, 2001;
98(10):
2958 - 2965.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Heydemann, S. Warming, C. Clendenin, K. Sigrist, J. P. Hjorth, and M. C. Simon
A minimal c-fes cassette directs myeloid-specific expression in transgenic mice
Blood,
November 1, 2000;
96(9):
3040 - 3048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Launay, B. Grossetete, M. Arcos-Fajardo, E. Gaudin, S. P. Torres, L. Beaudoin, N. Patey-Mariaud de Serre, A. Lehuen, and R. C. Monteiro
Fc{alpha} Receptor (CD89) Mediates the Development of Immunoglobulin A (IgA) Nephropathy (Berger's Disease): Evidence for Pathogenic Soluble Receptor-IgA Complexes in Patients and CD89 Transgenic Mice
J. Exp. Med.,
June 6, 1999;
191(11):
1999 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Hetherington, P. D. Kingsley, F. Crocicchio, P. Zhang, M. S. Rabin, J. Palis, and D.-E. Zhang
Characterization of Human Endotoxin Lipopolysaccharide Receptor CD14 Expression in Transgenic Mice
J. Immunol.,
January 1, 1999;
162(1):
503 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ogilvy, A. G. Elefanty, J. Visvader, M. L. Bath, A. W. Harris, and J. M. Adams
Transcriptional Regulation of vav, a Gene Expressed Throughout the Hematopoietic Compartment
Blood,
January 15, 1998;
91(2):
419 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Borregaard and J. B. Cowland
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
Blood,
May 15, 1997;
89(10):
3503 - 3521.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E.-O. Bockamp, F. McLaughlin, B. Gottgens, A. M. Murrell, A. G. Elefanty, and A. R. Green
Distinct Mechanisms Direct SCL/tal-1 Expression in Erythroid Cells and CD34 Positive Primitive Myeloid Cells
J. Biol. Chem.,
March 28, 1997;
272(13):
8781 - 8790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Grisolano, R. L. Wesselschmidt, P. G. Pelicci, and T. J. Ley
Altered Myeloid Development and Acute Leukemia in Transgenic Mice Expressing PML-RARalpha Under Control of Cathepsin G Regulatory Sequences
Blood,
January 15, 1997;
89(2):
376 - 387.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|